|
Volumn 15, Issue 12, 2008, Pages 1825-1827
|
Streptococcus pneumoniae 19A-induced hemolytic-uremic syndrome: A new pathology?;Syndrome hémolytique et urémique à pneumocoque de sérotype 19A : une pathologie émergente ?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
CEFOTAXIME;
PNEUMOCOCCUS VACCINE;
VANCOMYCIN;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
SEROTYPE;
STREPTOCOCCUS PNEUMONIAE;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
ANTI-BACTERIAL AGENTS;
BLOOD TRANSFUSION;
CEFOTAXIME;
CEREBROSPINAL FLUID;
DRUG THERAPY, COMBINATION;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
INFANT;
MAGNETIC RESONANCE IMAGING;
MALE;
PNEUMOCOCCAL INFECTIONS;
STREPTOCOCCUS PNEUMONIAE;
TREATMENT OUTCOME;
VANCOMYCIN;
|
EID: 57049151267
PISSN: 0929693X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.arcped.2008.09.023 Document Type: Letter |
Times cited : (5)
|
References (7)
|